- gsearch

- gsearch

CDC Stacks Public Health Publications

Search Results

Narrow Results:
Publication Year
Medical Subject
Personal Author
  • Surie, Diya (14)
Corporate Author
Place as Subject
Resource Type General
Resource Type Specific
Keywords
  • Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV a descriptive analysis of 23 countries in subSaharan Africa 20102015
    Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010–2015
    :
    :
  • Tuberculosis preventive treatment the next chapter of tuberculosis elimination in India
    Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
    :
    :
  • Molecular Spatial and Field Epidemiology Suggesting TB Transmission in Community Not Hospital Gaborone Botswana
    Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana
    :
    :
  • Effectiveness of adult respiratory syncytial virus RSV vaccines 20232024
    Effectiveness of adult respiratory syncytial virus (RSV) vaccines, 2023–2024
    :
    :
  • Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 COVID19 in the United States After Introduction of COVID19 Vaccines March 2021August 2022
    Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
    :
    :
  • Isoniazidassociated pellagra during mass scaleup of tuberculosis preventive therapy a casecontrol study
    Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study
    :
    :
  • Effectiveness of mRNA Vaccination in Preventing COVID19Associated Invasive Mechanical Ventilation and Death  United States March 2021January 2022
    Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
    :
    :
  • Effectiveness of COVID19 mRNA Vaccines Against COVID19Associated Hospitalization  Five Veterans Affairs Medical Centers US February 1August 6 2021
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, U.S. February 1–August 6, 2021
    :
    :
  • Comparative Effectiveness and Antibody Responses to Moderna and PfizerBioNTech COVID19 Vaccines among Hospitalized Veterans  Five Veterans Affairs Medical Centers US February 1September 30 2021
    Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, U.S. February 1–September 30, 2021
    :
    :
  • Effectiveness of MRNA Vaccination in Preventing COVID19associated Invasive Mechanical Ventilation and Death  United States March 2021January 2022
    Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
    :
    :
  • Effectiveness of COVID19 MRNA Vaccines Against COVID19associated Hospitalization  Five Veterans Affairs Medical Centers United States February 1August 6 2021
    Effectiveness of COVID-19 MRNA Vaccines Against COVID-19–associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
    :
    :
  • Effectiveness of a Third Dose of PfizerBioNTech and Moderna Vaccines in Preventing COVID19 Hospitalization Among Immunocompetent and Immunocompromised Adults  United States AugustDecember 2021
    Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
    :
    :
  • Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID19Associated Hospitalization Among Immunocompetent Adults Aged 65 Years  IVY Network 18 States September 8November 30 2022
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
    :
    :
  • Effectiveness of Monovalent mRNA Vaccines Against COVID19Associated Hospitalization Among Immunocompetent Adults During BA1BA2 and BA4BA5 Predominant Periods of SARSCoV2 Omicron Variant in the United States  IVY Network 18 States December 26 2021August 31 2022
    Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022
    :
    :